tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PCVX Stock Latest News

Vaxcyte’s Upcoming Data and Attractive Valuation: Buy Rating Reaffirmed
RatingsVaxcyte’s Upcoming Data and Attractive Valuation: Buy Rating Reaffirmed
12d ago
PCVX
Vaxcyte’s Promising Pipeline and Growth Potential Justifies Buy Rating
PremiumRatings
Vaxcyte’s Promising Pipeline and Growth Potential Justifies Buy Rating
16d ago
PCVX
Vaxcyte’s Promising Market Position and Innovative Approach Justify Buy Rating
PremiumRatings
Vaxcyte’s Promising Market Position and Innovative Approach Justify Buy Rating
16d ago
PCVX
Vaxcyte advances second stage of Phase 2 study evaluating VAX-31
PremiumThe Fly
Vaxcyte advances second stage of Phase 2 study evaluating VAX-31
18d ago
PCVX
Vaxcyte initiated with a Buy at Goldman Sachs
PremiumThe Fly
Vaxcyte initiated with a Buy at Goldman Sachs
2M ago
PCVX
Vaxcyte initiates Phase 2 study of VAX-31
PremiumThe FlyVaxcyte initiates Phase 2 study of VAX-31
3M ago
PCVX
Trump expected to pick Martin Makary to head FDA, Reuters reports
Premium
The Fly
Trump expected to pick Martin Makary to head FDA, Reuters reports
3M ago
GSK
PFE
Vaccine makers fall after Trump nominates RFK to head HHS
Premium
The Fly
Vaccine makers fall after Trump nominates RFK to head HHS
3M ago
GSK
PFE
Vaxcyte provides regulatory updates on VAX-31 programs
PremiumThe Fly
Vaxcyte provides regulatory updates on VAX-31 programs
3M ago
PCVX
Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges
PremiumCompany Announcements
Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges
4M ago
PCVX
Vaxcyte Reports Progress and Strengthens Financial Position
PremiumCompany Announcements
Vaxcyte Reports Progress and Strengthens Financial Position
4M ago
PCVX
Vaxcyte reports Q3 EPS (83c), consensus ($1.13)
PremiumThe Fly
Vaxcyte reports Q3 EPS (83c), consensus ($1.13)
4M ago
PCVX
PCVX Earnings this Week: How Will it Perform?
PremiumPre-EarningsPCVX Earnings this Week: How Will it Perform?
4M ago
PCVX
Vaxcyte management to meet with Cantor Fitzgerald
Premium
The Fly
Vaxcyte management to meet with Cantor Fitzgerald
5M ago
PCVX
Vaxcyte price target raised to $163 from $113 at Mizuho
Premium
The Fly
Vaxcyte price target raised to $163 from $113 at Mizuho
6M ago
PCVX
Vaxcyte 10.2M share Secondary priced at $103.00
PremiumThe Fly
Vaxcyte 10.2M share Secondary priced at $103.00
6M ago
PCVX
Vaxcyte price target raised to $130 from $101 at Guggenheim
PremiumThe Fly
Vaxcyte price target raised to $130 from $101 at Guggenheim
6M ago
PCVX
Vaxcyte price target raised to $140 from $101 at BofA
PremiumThe Fly
Vaxcyte price target raised to $140 from $101 at BofA
6M ago
PCVX
Vaxcyte announces $1B common stock and warrants offering
PremiumThe Fly
Vaxcyte announces $1B common stock and warrants offering
6M ago
PCVX
Vaxcyte price target raised to $153 at Leerink after VAX-31 ‘home run’
PremiumThe FlyVaxcyte price target raised to $153 at Leerink after VAX-31 ‘home run’
6M ago
PCVX
Needham ups Vaxcyte target to $140 after ‘best-case scenario’ data
Premium
The Fly
Needham ups Vaxcyte target to $140 after ‘best-case scenario’ data
6M ago
PCVX
Vaxcyte price target raised to $140 from $95 at Needham
Premium
The Fly
Vaxcyte price target raised to $140 from $95 at Needham
6M ago
PCVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >